| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
OB Preeclampsia Test (sFLT-1/PlGF Ratio)
MessagePerformed in Chemistry
BUMCT performs for BUMCS, CCN, and CCOG
BUMCP performs for the rest of AZ
BUMCT performs for BUMCS, CCN, and CCOG
BUMCP performs for the rest of AZ
Test Code
PREECLAMP
Preferred Specimen
1 mL Red top, serum (no gel), 0.5 mL min
Specimen Stability
Room temperature - 6 days
Refrigerated - 15 days
Frozen - 6 months
Refrigerated - 15 days
Frozen - 6 months
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Collected in an outdated/expired tube
Hemolyzed, icteric or lipemic
Contaminated
Collected in gel serum separator tube
Hemolyzed, icteric or lipemic
Contaminated
Collected in gel serum separator tube
Setup Schedule
Daily, Sunday through Saturday
Report Available
Less than 4 hours
Clinical Significance
The Preeclampsia Screen is designed to support clinical decision-making for high-risk obstetric patients presenting with hypertensive disorders of pregnancy, in alignment with current evidence-based guidelines. The sFlt-1/PlGF ratio provides valuable information to aid in the risk assessment of progression to preeclampsia with severe features within 2 weeks from presentation.
Patient Population
Patient Population
- High-risk obstetric patients with severe features )as defined by ACOG guidelines)
- Singleton pregnancy between 23 and 34 +6/7 gestation
- This assay should not be used in pregnant women receiving heparin within 36 hours of specimen collection
